Trial Profile
Study of ustekinumab induction associated with comparable circulating drug levels and early clinical response in Crohn's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jul 2018
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Crohn's disease
- Focus Pharmacokinetics; Therapeutic Use
- 17 Jul 2018 New trial record
- 19 Jun 2018 Results published in the Alimentary Pharmacology and Therapeutics